• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

准分子激光冠状动脉斑块切除术治疗支架内再狭窄慢性完全闭塞的疗效。

The therapeutic effects of excimer laser coronary atherectomy therapy for in-stent restenosis chronic total occlusions.

机构信息

Peking University Fifth School of Clinical Medicine, Beijing, People's Republic of China.

Cardiology Department, Beijing Hospital, National Center of Gerontology, Beijing, People's Republic of China.

出版信息

BMC Cardiovasc Disord. 2021 Aug 18;21(1):399. doi: 10.1186/s12872-021-02208-x.

DOI:10.1186/s12872-021-02208-x
PMID:34407770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8371826/
Abstract

OBJECTIVES

To evaluate the safety and efficacy of excimer laser coronary atherectomy (ELCA) in patients with in-stent restenosis chronic total occlusions (ISR CTOs).

BACKGROUND

ISR CTOs are a challenge in percutaneous coronary intervention (PCI). Although they can be treated by ELCA, limited data are available on the effects of ELCA treatment in these patients.

METHODS

Fifty-nine consecutive patients underwent PCI for ISR CTOs at Beijing Hospital between December 2017 and September 2020. According to whether or not ELCA was performed, they were divided into two groups. Quantitative coronary angiography (QCA) analyses were performed routinely, including measurement of the minimal lumen diameter and calculation of the percentage diameter stenosis. The procedural success rate, the frequency of peri-procedural complications, and the incidence rates of major adverse cardiac events (MACEs) over nine months were assessed. The primary endpoint in the study was the percentage diameter stenosis.

RESULTS

Procedure success was achieved in most patients in both groups (75.9%). Patients in the ELCA group exhibited a lower percentage diameter stenosis (24.5 ± 9.09 vs. 35.1 ± 18.6, p = 0.048) and a larger minimal lumen diameter (2.36 ± 0.29 mm vs. 1.78 ± 0.64 mm, p < 0.001) than those in the control group and the 9-month incidence rates of MACEs did not differ (9.5% vs 15.8%, p = 0.699).

CONCLUSIONS

This study demonstrated that ELCA may be a safe and effective technique in the treatment of ISR CTOs, and the use of ELCA can achieve good immediate angiographic results, as measured by QCA, without increasing peri-procedural complications or the incidence rates of 9-month MACEs.

摘要

目的

评估准分子激光冠状动脉斑块切除术(ELCA)治疗支架内再狭窄慢性完全闭塞病变(ISR CTO)患者的安全性和有效性。

背景

ISR CTO 是经皮冠状动脉介入治疗(PCI)的挑战。虽然可以通过 ELCA 进行治疗,但关于这些患者接受 ELCA 治疗的效果的数据有限。

方法

2017 年 12 月至 2020 年 9 月,北京医院对 59 例 ISR CTO 患者进行了 PCI。根据是否进行 ELCA 治疗,将患者分为两组。常规进行定量冠状动脉造影(QCA)分析,包括测量最小管腔直径和计算直径狭窄百分比。评估手术成功率、围手术期并发症发生率和 9 个月内主要不良心脏事件(MACE)发生率。研究的主要终点是直径狭窄百分比。

结果

两组患者的手术成功率均较高(75.9%)。ELCA 组患者的直径狭窄百分比较低(24.5±9.09%比 35.1±18.6%,p=0.048),最小管腔直径较大(2.36±0.29mm 比 1.78±0.64mm,p<0.001),与对照组相比,9 个月时 MACE 发生率无差异(9.5%比 15.8%,p=0.699)。

结论

本研究表明,ELCA 治疗 ISR CTO 可能是一种安全有效的技术,ELCA 的应用可通过 QCA 测量达到良好的即刻血管造影结果,而不会增加围手术期并发症或 9 个月时 MACE 的发生率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d0f/8371826/fafc33daa2da/12872_2021_2208_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d0f/8371826/dad19af328ca/12872_2021_2208_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d0f/8371826/23744917f8c8/12872_2021_2208_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d0f/8371826/fafc33daa2da/12872_2021_2208_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d0f/8371826/dad19af328ca/12872_2021_2208_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d0f/8371826/23744917f8c8/12872_2021_2208_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d0f/8371826/fafc33daa2da/12872_2021_2208_Fig3_HTML.jpg

相似文献

1
The therapeutic effects of excimer laser coronary atherectomy therapy for in-stent restenosis chronic total occlusions.准分子激光冠状动脉斑块切除术治疗支架内再狭窄慢性完全闭塞的疗效。
BMC Cardiovasc Disord. 2021 Aug 18;21(1):399. doi: 10.1186/s12872-021-02208-x.
2
Beyond the balloon: excimer coronary laser atherectomy used alone or in combination with rotational atherectomy in the treatment of chronic total occlusions, non-crossable and non-expansible coronary lesions.球囊之外:准分子冠状动脉激光消蚀术单独或与旋磨术联合用于治疗慢性完全闭塞、不可跨越和不可扩张的冠状动脉病变。
EuroIntervention. 2013 Jun 22;9(2):243-50. doi: 10.4244/EIJV9I2A40.
3
Treatment of In-Stent Restenosis Using Excimer Laser Coronary Atherectomy and Bioresorbable Vascular Scaffold Guided by Optical Coherence Tomography.在光学相干断层扫描引导下使用准分子激光冠状动脉斑块切除术和生物可吸收血管支架治疗支架内再狭窄
Cardiovasc Revasc Med. 2021 Jan;22:44-49. doi: 10.1016/j.carrev.2020.05.006. Epub 2020 May 14.
4
Long-Term Clinical Outcomes after Treatment with Excimer Laser Coronary Atherectomy for In-Stent Restenosis of Drug-Eluting Stent.准分子激光冠状动脉斑块旋切术治疗药物洗脱支架内再狭窄的长期临床结局
Int Heart J. 2018 Jan 27;59(1):14-20. doi: 10.1536/ihj.16-638. Epub 2018 Jan 15.
5
The combined use of Drug-eluting balloon and Excimer laser for coronary artery Restenosis In-Stent Treatment: The DERIST study.药物洗脱球囊与准分子激光联合用于冠状动脉支架内再狭窄治疗:DERIST研究
Cardiovasc Revasc Med. 2017 Apr-May;18(3):165-168. doi: 10.1016/j.carrev.2016.12.012. Epub 2016 Dec 21.
6
Long-term clinical outcomes of excimer laser coronary atherectomy for the management of recurrent in-stent restenosis.准分子激光冠状动脉斑块切除术治疗支架内再狭窄的长期临床结果。
J Invasive Cardiol. 2023 Jul;35(7):E365-E374. doi: 10.25270/jic/22.00380.
7
The efficacy of "hybrid" percutaneous coronary intervention in chronic total occlusions caused by in-stent restenosis: insights from a US multicenter registry.“杂交”经皮冠状动脉介入治疗支架内再狭窄所致慢性完全闭塞病变的疗效:来自美国多中心注册研究的见解
Catheter Cardiovasc Interv. 2014 Oct 1;84(4):646-51. doi: 10.1002/ccd.25465. Epub 2014 Jul 4.
8
Treatment of In-Stent Restenosis by Excimer Laser Coronary Atherectomy and Drug-Coated Balloon: Serial Assessment with Optical Coherence Tomography.准分子激光冠状动脉斑块切除术联合药物涂层球囊治疗支架内再狭窄:光学相干断层成像的系列评估。
J Interv Cardiol. 2019 Apr 18;2019:6515129. doi: 10.1155/2019/6515129. eCollection 2019.
9
Excimer laser atherectomy to overcome intraprocedural obstacles in chronic total occlusion percutaneous intervention: Case examples.准分子激光斑块消蚀术克服慢性完全闭塞经皮介入治疗中的术中障碍:病例举例。
Catheter Cardiovasc Interv. 2015 Feb 15;85(3):E83-9. doi: 10.1002/ccd.25680. Epub 2014 Oct 7.
10
Contrast-enhanced excimer laser stepwise approach during PCI for resistant coronary lesions.经皮冠状动脉介入治疗(PCI)中应用对比增强准分子激光分步消蚀术治疗难治性冠状动脉病变
Catheter Cardiovasc Interv. 2024 Aug;104(2):220-226. doi: 10.1002/ccd.31141. Epub 2024 Jul 3.

引用本文的文献

1
Laser Versus Rotational Atherectomy in Coronary Artery Disease: A Systematic Review and Meta-Analysis of Procedural Success and Safety.冠状动脉疾病中激光与旋磨术的比较:手术成功率及安全性的系统评价与荟萃分析
Cureus. 2025 May 26;17(5):e84832. doi: 10.7759/cureus.84832. eCollection 2025 May.
2
Consensus of National Heart Center and the Saudi Arabian Cardiac Interventional Society on the Current Landscape of the Management of Intracoronary Calcification in Saudi Arabia.沙特阿拉伯国家心脏中心与沙特阿拉伯心脏介入协会关于沙特阿拉伯冠状动脉钙化管理现状的共识
J Saudi Heart Assoc. 2024 Aug 1;36(2):158-173. doi: 10.37616/2212-5043.1385. eCollection 2024.
3

本文引用的文献

1
Long-term outcomes of percutaneous coronary intervention for in-stent chronic total occlusion.经皮冠状动脉介入治疗支架内慢性完全闭塞的长期结果。
Chin Med J (Engl). 2020 Dec 16;134(3):302-308. doi: 10.1097/CM9.0000000000001289.
2
Excimer Laser Atherectomy in Percutaneous Coronary Intervention: A Contemporary Review.准分子激光冠状动脉斑块切除术在经皮冠状动脉介入治疗中的应用:当代综述。
Cardiovasc Revasc Med. 2021 Apr;25:75-85. doi: 10.1016/j.carrev.2020.10.016. Epub 2020 Oct 27.
3
Trends and Outcomes of Restenosis After Coronary Stent Implantation in the United States.
Safety and Efficiency of Rotational Atherectomy in Chronic Total Coronary Occlusion-One-Year Clinical Outcomes of an Observational Registry.
慢性完全性冠状动脉闭塞病变中旋磨术的安全性和有效性——一项观察性注册研究的一年临床结果
J Clin Med. 2023 May 17;12(10):3510. doi: 10.3390/jcm12103510.
美国冠状动脉支架植入术后再狭窄的趋势和结果。
J Am Coll Cardiol. 2020 Sep 29;76(13):1521-1531. doi: 10.1016/j.jacc.2020.08.002.
4
Excimer laser coronary atherectomy during complex PCI: An analysis of 1,471 laser cases from the British Cardiovascular Intervention Society database.复杂经皮冠状动脉介入治疗期间的准分子激光冠状动脉斑块切除术:来自英国心血管介入学会数据库的1471例激光治疗病例分析。
Catheter Cardiovasc Interv. 2021 Apr 1;97(5):E653-E660. doi: 10.1002/ccd.29251. Epub 2020 Sep 18.
5
A comparison of procedural success rate and long-term clinical outcomes between in-stent restenosis chronic total occlusion and de novo chronic total occlusion using multicenter registry data.多中心注册研究数据比较支架内再狭窄慢性完全闭塞和初发慢性完全闭塞患者的介入治疗成功率和长期临床结局。
Clin Res Cardiol. 2020 May;109(5):628-637. doi: 10.1007/s00392-019-01550-7. Epub 2019 Sep 24.
6
'Ten Commandments' for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南的“十诫”
Eur Heart J. 2018 Nov 7;39(42):3759. doi: 10.1093/eurheartj/ehy658.
7
Fourth Universal Definition of Myocardial Infarction (2018).心肌梗死的第四次全球定义(2018年)。
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264. doi: 10.1016/j.jacc.2018.08.1038. Epub 2018 Aug 25.
8
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.经皮冠状动脉介入治疗临床试验的标准化终点定义:学术研究联合会-2 共识文件。
Circulation. 2018 Jun 12;137(24):2635-2650. doi: 10.1161/CIRCULATIONAHA.117.029289.
9
Incidence, Treatment, and Outcomes of Coronary Perforation During Chronic Total Occlusion Percutaneous Coronary Intervention.慢性完全闭塞性经皮冠状动脉介入治疗期间冠状动脉穿孔的发生率、治疗及结局
Am J Cardiol. 2017 Oct 15;120(8):1285-1292. doi: 10.1016/j.amjcard.2017.07.010. Epub 2017 Jul 24.
10
Procedural and Long-Term Outcomes of Percutaneous Coronary Intervention for In-Stent Chronic Total Occlusion.经皮冠状动脉介入治疗支架内慢性完全闭塞的操作及长期结果。
JACC Cardiovasc Interv. 2017 May 8;10(9):892-902. doi: 10.1016/j.jcin.2017.01.047. Epub 2017 Apr 12.